Innate Pharma S.A. (EPA: IPH)
France
· Delayed Price · Currency is EUR 1.584
+0.114 (7.76%)
Nov 20, 2024, 5:35 PM CET
Innate Pharma Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -34.05 | -7.57 | -58.1 | -52.81 | -63.98 | -20.76 | Upgrade
|
| Depreciation & Amortization | 2.59 | 5.09 | 4.41 | 4.6 | 13.27 | 16.53 | Upgrade
|
| Loss (Gain) From Sale of Assets | -1.09 | -0.52 | - | -0.37 | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 41 | - | 43.53 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -1.54 | -1.59 | 1.37 | -0.99 | 0.58 | -4.07 | Upgrade
|
| Stock-Based Compensation | 4.56 | 4.26 | 4.25 | 2.62 | 2.48 | 3.83 | Upgrade
|
| Other Operating Activities | -1.56 | -0.13 | 0.43 | -1.62 | 1.57 | -0.85 | Upgrade
|
| Change in Accounts Receivable | 22.17 | -13.67 | -4.2 | - | -22.92 | - | Upgrade
|
| Change in Accounts Payable | -1.12 | -3.89 | -7.66 | - | -6.53 | - | Upgrade
|
| Change in Unearned Revenue | -4.11 | -4 | -23.43 | - | -45.14 | - | Upgrade
|
| Change in Other Net Operating Assets | -3.91 | -10.53 | 22.8 | -9.89 | 25.38 | 40.25 | Upgrade
|
| Operating Cash Flow | -18.06 | -32.56 | -19.16 | -58.46 | -51.77 | 34.92 | Upgrade
|
| Capital Expenditures | -0.33 | -0.35 | -0.54 | -0.93 | -0.91 | -1.27 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.15 | 0.15 | - | 0.01 | 0.01 | - | Upgrade
|
| Sale (Purchase) of Intangibles | -2 | -2 | -0.59 | -0.4 | -10.38 | -64.13 | Upgrade
|
| Investment in Securities | 23.98 | 22.77 | 3 | - | -3 | 2 | Upgrade
|
| Other Investing Activities | 0 | 0.06 | -0 | 0.41 | 0.9 | 1.28 | Upgrade
|
| Investing Cash Flow | 21.81 | 20.63 | 1.88 | -0.92 | -13.37 | -62.12 | Upgrade
|
| Long-Term Debt Issued | - | - | - | 28.7 | 1.36 | 13.9 | Upgrade
|
| Long-Term Debt Repaid | - | -2.36 | -2.03 | -2.07 | -2.25 | -1.98 | Upgrade
|
| Net Debt Issued (Repaid) | -5.19 | -2.36 | -2.03 | 26.63 | -0.89 | 11.92 | Upgrade
|
| Issuance of Common Stock | 0.14 | 0.4 | 0.2 | 0.5 | 0.05 | 66.05 | Upgrade
|
| Other Financing Activities | - | - | - | -0.31 | -0.34 | -0.2 | Upgrade
|
| Financing Cash Flow | -5.05 | -1.97 | -1.83 | 26.82 | -1.18 | 77.77 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.13 | 0.27 | -0.43 | -0.48 | 0.22 | 0.01 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | 0 | -0 | -0 | - | Upgrade
|
| Net Cash Flow | -1.42 | -13.62 | -19.53 | -33.04 | -66.1 | 50.57 | Upgrade
|
| Free Cash Flow | -18.38 | -32.91 | -19.69 | -59.39 | -52.67 | 33.65 | Upgrade
|
| Free Cash Flow Margin | -54.40% | -53.39% | -34.14% | -240.40% | -75.49% | 39.38% | Upgrade
|
| Free Cash Flow Per Share | -0.23 | -0.41 | -0.25 | -0.75 | -0.67 | 0.50 | Upgrade
|
| Cash Interest Paid | - | - | - | 0.31 | 0.34 | 0.2 | Upgrade
|
| Levered Free Cash Flow | 13.06 | -27.07 | -32.74 | -15.02 | -74.5 | 13.48 | Upgrade
|
| Unlevered Free Cash Flow | 13.44 | -26.67 | -32.56 | -14.82 | -74.28 | 13.61 | Upgrade
|
| Change in Net Working Capital | -32.73 | 25.75 | 29.83 | -9.19 | 79.42 | -57.67 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.